Takeda Invites Banks to Join $31 Billion Loan for Shire Deal
- Interest margin, commitment fee based on Takeda’s debt rating
- Lenders need to commit at least about $500 million ticket
This article is for subscribers only.
Takeda Pharmaceutical Co. has invited Japanese and overseas banks to participate in the syndication of the $30.85 billion loan to back its $62 billion purchase of Shire Plc, according to people familiar with the matter.
The move comes after the Japanese pharma giant said earlier this month it had reached an agreement on the bridge loan with JPMorgan Chase, MUFG Bank and Sumitomo Mitsui Banking Corp. The syndication gives more lenders an opportunity to get in on one of the biggest ever loans in Asia, which has helped drive up the average loan size for high-grade acquisitions worldwide this year.